BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Panacea Biotec Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
531349
ISIN Demat
INE922B01023
Book Value (Rs)
46.5684246
NSE Symbol
PANACEABIO
Divident Yield %
0
Market Cap
(Rs In Cr.)
3,214
P/E (TTM)
0
EPS (TTM)
0
Face Value
(Rs)
1
Back
Panacea Biotec consolidated net profit declines 11.95% in the December 2025 quarter
12-Feb-26   Hrs IST

Net profit of Panacea Biotec declined 11.95% to Rs 3.98 crore in the quarter ended December 2025 as against Rs 4.52 crore during the previous quarter ended December 2024. Sales rose 1.04% to Rs 165.19 crore in the quarter ended December 2025 as against Rs 163.49 crore during the previous quarter ended December 2024.

ParticularsQuarter Ended
Dec. 2025Dec. 2024% Var.
Sales165.19163.49 1
OPM %7.114.87 -
PBDT12.1710.59 15
PBT3.721.61 131
NP3.984.52 -12

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)